ATE168698T1 - Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten - Google Patents

Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten

Info

Publication number
ATE168698T1
ATE168698T1 AT89906251T AT89906251T ATE168698T1 AT E168698 T1 ATE168698 T1 AT E168698T1 AT 89906251 T AT89906251 T AT 89906251T AT 89906251 T AT89906251 T AT 89906251T AT E168698 T1 ATE168698 T1 AT E168698T1
Authority
AT
Austria
Prior art keywords
psoriasis
treatment
preparations
neuropsychiatric diseases
useful
Prior art date
Application number
AT89906251T
Other languages
English (en)
Inventor
Peter Bridge
Frederick K Goodwin
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/352,313 external-priority patent/US5063206A/en
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE168698T1 publication Critical patent/ATE168698T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT89906251T 1988-05-27 1989-05-25 Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten ATE168698T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19987388A 1988-05-27 1988-05-27
US28555988A 1988-12-16 1988-12-16
US07/352,313 US5063206A (en) 1988-12-16 1989-05-16 Compositions having use as treatment of neuropsychiatric deficits

Publications (1)

Publication Number Publication Date
ATE168698T1 true ATE168698T1 (de) 1998-08-15

Family

ID=27394077

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89906251T ATE168698T1 (de) 1988-05-27 1989-05-25 Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten

Country Status (8)

Country Link
EP (1) EP0415999B1 (de)
JP (2) JPH0618777B2 (de)
AT (1) ATE168698T1 (de)
AU (1) AU620107B2 (de)
CA (1) CA1336677C (de)
DE (1) DE68928752T2 (de)
IL (1) IL90427A (de)
WO (1) WO1989012067A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242564B1 (en) * 1986-06-03 2001-06-05 Candace B. Pert Treatment of tropical spastic paresis with peptide T
US5189022A (en) * 1988-05-27 1993-02-23 The United States Of America As Represented By The Secretary Of Health And Human Services Composition for the treatment of chronic fatigue syndrome
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
ZA932233B (en) * 1992-03-27 1994-09-29 Peptide Technology Ltd Peptide T and related peptides in the treatment of inflammation including multiple sclerosis
US6011014A (en) * 1992-03-27 2000-01-04 Advanced Immunit, Inc. Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
DK0635027T3 (da) * 1992-03-27 2000-10-02 Advanced Immunit T Inc Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose
DK0871466T3 (da) * 1993-09-24 2004-08-16 Advanced Immuni T Inc Lineære og cykliske peptider til behandling eller forebyggelse af eksem/dermatitis
AU7735194A (en) * 1993-09-24 1995-04-10 Peptide Technology Limited Treatment or prevention of Crohn's disease and/or ulcerative colitis
JP3863829B2 (ja) 2002-08-27 2006-12-27 ペンタックス株式会社 ズームレンズ鏡筒の繰出カム機構及び繰出カム機構
JP2004085932A (ja) 2002-08-27 2004-03-18 Pentax Corp ズームレンズ鏡筒の繰出カム機構及び繰出カム機構
US7058293B2 (en) 2002-08-27 2006-06-06 Pentax Corporation Optical element retracting mechanism for a retractable lens
US7085486B2 (en) 2002-08-27 2006-08-01 Pentax Corporation Lens barrel incorporating a rotatable ring

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921613A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd 直腸投与製剤
ATE96450T1 (de) * 1986-06-03 1993-11-15 Us Commerce Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken.
AU7544987A (en) * 1986-06-03 1988-01-11 Pert, C.B. Small peptides which inhibit binding to t-4 receptors
US4804651A (en) * 1987-06-09 1989-02-14 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of psoriasis
PT90657B (pt) * 1988-05-27 1995-03-01 Ortho Pharma Corp Processo para a preparacao de peptidos que bloqueiam a ligacao de hiv-1 a proteina cd4 receptora

Also Published As

Publication number Publication date
EP0415999B1 (de) 1998-07-22
DE68928752D1 (de) 1998-08-27
EP0415999A4 (en) 1991-10-16
CA1336677C (en) 1995-08-15
IL90427A (en) 1994-10-07
WO1989012067A1 (en) 1989-12-14
DE68928752T2 (de) 1998-12-03
AU620107B2 (en) 1992-02-13
EP0415999A1 (de) 1991-03-13
JPH03502928A (ja) 1991-07-04
JPH0618777B2 (ja) 1994-03-16
AU3693689A (en) 1990-01-05
JPH06228001A (ja) 1994-08-16
JP3011837B2 (ja) 2000-02-21

Similar Documents

Publication Publication Date Title
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
NO985975L (no) Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav
ES2150482T3 (es) Pirazolopirimidinas como antagonistas del factor liberador de corticotropina.
FI935585A0 (fi) Pyrrolopyrimidiner
DE60039752D1 (de) Herstellung tetravalenter antikörper
DE3779346D1 (de) Zusammensetzung zur behandlung der haut.
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
ATE168698T1 (de) Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
ATE190623T1 (de) Verwendung von steroiden zur inhibierung von angiogenesis
ATE100320T1 (de) Verwendung von thromboxan-a2-rezeptorantagonisten zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von hautkrankheiten.
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
ATE82857T1 (de) Interleukin-2-zusammensetzungen.
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE189604T1 (de) Extrakte von piliostigma thonningii, deren verwendung und diese enthaltende zubereitungen
TR200000916T2 (tr) İkameli piperidin türevleri.
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.
DE3765250D1 (de) Verwendung von 24,25-dihydroxycholecalciferol zur behandlung von harnsteinen.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time